Engineering Enhanced Immunogenicity of Surface-Displayed Immunogens in a Killed Whole-Cell Genome-Reduced Bacterial Vaccine Platform Using Class I Viral Fusion Peptides
<b>Background/Objectives</b>: New vaccine platforms that rapidly yield low-cost, easily manufactured vaccines are highly desired, yet current approaches lack key features. We developed the Killed Whole-Cell/Genome-Reduced Bacteria (KWC/GRB) platform, which uses a genome-reduced Gram-negative chassis...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2025-12-01
|
| シリーズ: | Vaccines |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2076-393X/14/1/14 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
